West Nile Virus Infection in the Central Nervous System

F1000Research

Volumn 5, Issue , 2016, Pages

  Wang, Tian ^a   Winkelmann, Evandro R ^a   Luo, Huanle ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84970971273     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.7404.1     Document Type: Review

References (107)

1. Nash D Mostashari F Fine A: The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344(24):1807-14. 11407341 10.1056/NEJM200106143442401
2. Centers for Disease Control and Prevention (CDC): Laboratory-acquired West Nile virus infections--United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51(50):1133-5. 12537288
3. Charatan F: Organ transplants and blood transfusions may transmit West Nile virus. BMJ. 2002;325(7364):566. 12228130 10.1136/bmj.325.7364.566/a 1169473
4. Centers for Disease Control and Prevention (CDC): Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002;51(39):877-8. 12375687
5. Alpert SG Fergerson J Noël LP: Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol. 2003;136(4):733-5. 14516816 10.1016/S0002-9394(03)00452-5
6. Hayes EB O'Leary DR: West Nile virus infection: a pediatric perspective. Pediatrics. 2004;113(5):1375-81. 15121956
7. Hinckley AF O'Leary DR Hayes EB: Transmission of West Nile virus through human breast milk seems to be rare. Pediatrics. 2007;119(3):e666-71. 17332186 F1000 Recommendation
8. Petersen LR Brault AC Nasci RS: West Nile virus: review of the literature. JAMA. 2013;310(3):308-15. 23860989 10.1001/jama.2013.8042 4563989
9. Carson PJ Konewko P Wold KS: Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis. 2006;43(6):723-30. 16912946 10.1086/506939 F1000 Recommendation
10. Ou AC Ratard RC: One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana. J La State Med Soc. 2005;157(1):42-6. 15887668
11. Cook RL Xu X Yablonsky EJ: Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am J Trop Med Hyg. 2010;83(5):1133-6. 21036852 10.4269/ajtmh.2010.09-0717 2963984
12. Sadek JR Pergam SA Harrington JA: Persistent neuropsychological impairment associated with West Nile virus infection. J Clin Exp Neuropsychol. 2010;32(1):81-7. 19513920 10.1080/13803390902881918 F1000 Recommendation
13. Nolan MS Podoll AS Hause AM: Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PLoS One. 2012;7(7):e40374. 22792293 10.1371/journal.pone.0040374 3391259
14. Patel H Sander B Nelder MP: Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect Dis. 2015;15(8):951-9. 26163373 10.1016/S1473-3099(15)00134-6
15. Sejvar JJ: Clinical manifestations and outcomes of West Nile virus infection. Viruses. 2014;6(2):606-23. 24509812 10.3390/v6020606 3939474
16. Weatherhead JE Miller VE Garcia MN: Long-term neurological outcomes in West Nile virus-infected patients: an observational study. Am J Trop Med Hyg. 2015;92(5):1006-12. 25802426 10.4269/ajtmh.14-0616 4426557
17. Anastasiadou A Kakoulidis I Butel D: Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis. 2013;17(7):e494-7. 23317528 10.1016/j.ijid.2012.12.006
18. Centers for Disease Control and Prevention (CDC): West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(45):1263-7. 19940831
19. Nett RJ Kuehnert MJ Ison MG: Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis. 2012;14(3):268-77. 22606990 10.1111/j.1399-3062.2012.00743.x
20. Tilley PA Fox JD Lee B: Screening of organ and tissue donors for West Nile virus by nucleic acid amplification--a three year experience in Alberta. Am J Transplant. 2008;8(10):2119-25. 18727691 10.1111/j.1600-6143.2008.02365.x
21. Beasley DW Li L Suderman MT: Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology. 2002;296(1):17-23. 12036314 10.1006/viro.2002.1372
22. Samuel MA Diamond MS: Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol. 2006;80(19):9349-60. 16973541 10.1128/JVI.01122-06 1617273
23. Wang T Fikrig E: Immunity to West Nile virus. Curr Opin Immunol. 2004;16(4):519-23. 15245749 10.1016/j.coi.2004.05.008
24. Hayes EB Komar N Nasci RS: Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005;11(8):1167-73. 16102302 10.3201/eid1108.050289a 3320478
25. Byrne SN Halliday GM Johnston LJ: Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol. 2001;117(3):702-9. 11564180 10.1046/j.0022-202x.2001.01454.x
26. Lim PY Behr MJ Chadwick CM: Keratinocytes are cell targets of West Nile virus in vivo. J Virol. 2011;85(10):5197-201. 21367890 10.1128/JVI.02692-10 3126165
27. Welte T Reagan K Fang H: Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J Gen Virol. 2009;90(Pt 11):2660-8. 19641044 10.1099/vir.0.011783-0 2771433
28. Kramer LD Bernard KA: West Nile virus infection in birds and mammals. Ann N Y Acad Sci. 2001;951:84-93. 11797807 10.1111/j.1749-6632.2001.tb02687.x
29. Diamond MS Sitati EM Friend LD: A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med. 2003;198(12):1853-62. 14662909 10.1084/jem.20031223 2194144
30. Brightman MW Ishihara S Chang L: Penetration of solutes, viruses, and cells across the blood-brain barrier. Curr Top Microbiol Immunol. 1995;202:63-78. 7587371 10.1007/978-3-642-79657-9_5
31. Engelhardt B: Development of the blood-brain barrier. Cell Tissue Res. 2003;314(1):119-29. 12955493 10.1007/s00441-003-0751-z
32. Arjona A Foellmer HG Town T: Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest. 2007;117(10):3059-66. 17909632 10.1172/JCI32218 1994625
33. Daniels BP Holman DW Cruz-Orengo L: Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio. 2014;5(5):e01476-14. 25161189 10.1128/mBio.01476-14 4173776 F1000 Recommendation
34. Wang T Town T Alexopoulou L: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004;10(12):1366-73. 15558055 10.1038/nm1140 F1000 Recommendation
35. Wang P Dai J Bai F: Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol. 2008;82(18):8978-85. 18632868 10.1128/JVI.00314-08 2546894 F1000 Recommendation
36. Sultana H Neelakanta G Foellmer HG: Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling. J Immunol. 2012;189(6):3150-8. 22896629 10.4049/jimmunol.1201140 3496209 F1000 Recommendation
37. Bhattacharyya S Zagórska A Lew ED: Enveloped Viruses Disable Innate Immune Responses in Dendritic Cells by Direct Activation of TAM Receptors. Cell Host Microbe. 2013;14(2):136-47. 23954153 10.1016/j.chom.2013.07.005 3779433 F1000 Recommendation
38. Miner JJ Daniels BP Shrestha B: The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Nat Med. 2015;21(12):1464-72. 26523970 10.1038/nm.3974 4674389 F1000 Recommendation
39. Lazear HM Daniels BP Pinto AK: Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med. 2015;7(284):284ra59. 25904743 10.1126/scitranslmed.aaa4304 4435724 F1000 Recommendation
40. Roe K Orillo B Verma S: West Nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model. PLoS One. 2014;9(7):e102598. 25036379 10.1371/journal.pone.0102598 4103843
41. Dai J Wang P Bai F: Icam-1 participates in the entry of west nile virus into the central nervous system. J Virol. 2008;82(8):4164-8. 18256150 10.1128/JVI.02621-07 2292986
42. Verma S Lo Y Chapagain M: West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology. 2009;385(2):425-33. 19135695 10.1016/j.virol.2008.11.047 2684466 F1000 Recommendation
43. Bai F Kong KF Dai J: A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis. 2010;202(12):1804-12. 21050124 10.1086/657416 3053000 F1000 Recommendation
44. Wang S Welte T McGargill M: Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol. 2008;181(3):2084-91. 18641347 10.4049/jimmunol.181.3.2084 2494872
45. Hunsperger EA Roehrig JT: Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice. J Neurovirol. 2006;12(2):129-39. 16798674 10.1080/13550280600758341
46. Samuel MA Wang H Siddharthan V: Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A. 2007;104(43):17140-5. 17939996 10.1073/pnas.0705837104 2040476
47. Monath TP Cropp CB Harrison AK: Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest. 1983;48(4):399-410. 6300550
48. Errett JS Suthar MS McMillan A: The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol. 2013;87(21):11416-25. 23966395 10.1128/JVI.01488-13 3807316
49. Town T Bai F Wang T: Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity. 2009;30(2):242-53. 19200759 10.1016/j.immuni.2008.11.012 2707901 F1000 Recommendation
50. Fredericksen BL Keller BC Fornek J: Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol. 2008;82(2):609-16. 17977974 10.1128/JVI.01305-07 2224571
51. Katze MG He Y Gale M Jr: Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2(9):675-87. 12209136 10.1038/nri888
52. Samuel MA Diamond MS: Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol. 2005;79(21):13350-61. 16227257 10.1128/JVI.79.21.13350-13361.2005 1262587
53. Lazear HM Pinto AK Vogt MR: Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol. 2011;85(14):7186-94. 21543483 10.1128/JVI.00396-11 3126609
54. Thackray LB Shrestha B Richner JM: Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection. J Virol. 2014;88(19):11007-21. 25031348 10.1128/JVI.01545-14 4178807
55. Wang T Scully E Yin Z: IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J Immunol. 2003;171(5):2524-31. 12928402 10.4049/jimmunol.171.5.2524
56. Shrestha B Wang T Samuel MA: Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol. 2006;80(11):5338-48. 16699014 10.1128/JVI.00274-06 1472130
57. Welte T Lamb J Anderson JF: Role of two distinct gammadelta T cell subsets during West Nile virus infection. FEMS Immunol Med Microbiol. 2008;53(2):275-83. 18513355 10.1111/j.1574-695X.2008.00430.x 2755494
58. Fang H Welte T Zheng X: gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol. 2010;59(1):71-80. 20337718 10.1111/j.1574-695X.2010.00663.x 2954433
59. Wang T Gao Y Scully E: Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice. J Immunol. 2006;177(3):1825-32. 16849493 10.4049/jimmunol.177.3.1825
60. Diamond MS Shrestha B Marri A: B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003;77(4):2578-86. 12551996 10.1128/JVI.77.4.2578-2586.2003 141119
61. Diamond MS Shrestha B Mehlhop E: Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 2003;16(3):259-78. 14583143 10.1089/088282403322396082
62. Roehrig JT Staudinger LA Hunt AR: Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci. 2001;951:286-97. 11797785 10.1111/j.1749-6632.2001.tb02704.x
63. Mehlhop E Diamond MS: Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med. 2006;203(5):1371-81. 16651386 10.1084/jem.20052388 2121216
64. Mehlhop E Whitby K Oliphant T: Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol. 2005;79(12):7466-77. 15919902 10.1128/JVI.79.12.7466-7477.2005 1143684
65. Kulkarni AB Müllbacher A Blanden RV: Functional analysis of macrophages, B cells and splenic dendritic cells as antigen-presenting cells in West Nile virus-specific murine T lymphocyte proliferation. Immunol Cell Biol. 1991;69(Pt 2):71-80. 1680803 10.1038/icb.1991.12
66. Liu Y Blanden RV Müllbacher A: Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system. J Gen Virol. 1989;70(Pt 3):565-73. 2543751 10.1099/0022-1317-70-3-565
67. Sitati EM Diamond MS: CD4 + T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol. 2006;80(24):12060-9. 17035323 10.1128/JVI.01650-06 1676257 F1000 Recommendation
68. Shrestha B Diamond MS: Role of CD8 + T cells in control of West Nile virus infection. J Virol. 2004;78(15):8312-21. 15254203 10.1128/JVI.78.15.8312-8321.2004 446114 F1000 Recommendation
69. Lanteri MC O'Brien KM Purtha WE: Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest. 2009;119(11):3266-77. 19855131 10.1172/JCI39387 2769173 F1000 Recommendation
70. Graham JB Da Costa A Lund JM: Regulatory T cells shape the resident memory T cell response to virus infection in the tissues. J Immunol. 2014;192(2):683-90. 24337378 10.4049/jimmunol.1202153 3894741 F1000 Recommendation
71. Suthar MS Ma DY Thomas S: IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 2010;6(2):e1000757. 20140199 10.1371/journal.ppat.1000757 2816698 F1000 Recommendation
72. Campbell GL Marfin AA Lanciotti RS: West Nile virus. Lancet Infect Dis. 2002;2(9):519-29. 12206968 10.1016/S1473-3099(02)00368-7
73. Solomon T Ooi MH Beasley DW: West Nile encephalitis. BMJ. 2003;326(7394):865-9. 12702624 10.1136/bmj.326.7394.865 1125772
74. Brien JD Uhrlaub JL Hirsch A: Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med. 2009;206(12):2735-45. 19901080 10.1084/jem.20090222 2806630 F1000 Recommendation
75. Richner JM Gmyrek GB Govero J: Age-Dependent Cell Trafficking Defects in Draining Lymph Nodes Impair Adaptive Immunity and Control of West Nile Virus Infection. PLoS Pathog. 2015;11(7):e1005027. 26204259 10.1371/journal.ppat.1005027 4512688 F1000 Recommendation
76. Quick ED Leser JS Clarke P: Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection. J Virol. 2014;88(22):13005-14. 25165111 10.1128/JVI.01994-14 4249089 F1000 Recommendation
77. Shrestha B Gottlieb D Diamond MS: Infection and injury of neurons by West Nile encephalitis virus. J Virol. 2003;77(24):13203-13. 14645577 10.1128/JVI.77.24.13203-13213.2003 296085
78. Cho H Shrestha B Sen GC: A role for Ifit2 in restricting West Nile virus infection in the brain. J Virol. 2013;87(15):8363-71. 23740986 10.1128/JVI.01097-13 3719802 F1000 Recommendation
79. Cho H Proll SC Szretter KJ: Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013;19(4):458-64. 23455712 10.1038/nm.3108 3618596 F1000 Recommendation
80. Ramos HJ Lanteri MC Blahnik G: IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012;8(11):e1003039. 23209411 10.1371/journal.ppat.1003039 3510243 F1000 Recommendation
81. Daffis S Samuel MA Suthar MS: Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 2008;82(21):10349-58. 18715906 10.1128/JVI.00935-08 2573187 F1000 Recommendation
82. Szretter KJ Daffis S Patel J: The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J Virol. 2010;84(23):12125-38. 20881045 10.1128/JVI.01026-10 2976388 F1000 Recommendation
83. Wang P Arjona A Zhang Y: Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat Immunol. 2010;11(10):912-9. 20818395 10.1038/ni.1933 3712356 F1000 Recommendation
84. Town T Jeng D Alexopoulou L: Microglia recognize double-stranded RNA via TLR3. J Immunol. 2006;176(6):3804-12. 16517751 10.4049/jimmunol.176.6.3804
85. Hussmann KL Samuel MA Kim KS: Differential replication of pathogenic and nonpathogenic strains of West Nile virus within astrocytes. J Virol. 2013;87(5):2814-22. 23269784 10.1128/JVI.02577-12 3571364
86. Zhang B Chan YK Lu B: CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol. 2008;180(4):2641-9. 18250476 10.4049/jimmunol.180.4.2641 F1000 Recommendation
87. Klein RS Lin E Zhang B: Neuronal CXCL10 directs CD8 + T-cell recruitment and control of West Nile virus encephalitis. J Virol. 2005;79(17):11457-66. 16103196 10.1128/JVI.79.17.11457-11466.2005 1193600 F1000 Recommendation
88. Glass WG Lim JK Cholera R: Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med. 2005;202(8):1087-98. 16230476 10.1084/jem.20042530 2213214 F1000 Recommendation
89. Bréhin AC Mouriès J Frenkiel MP: Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19 +B220 -BST-2 + leukocyte population. J Immunol. 2008;180(10):6760-7. 18453596 10.4049/jimmunol.180.10.6760
90. Lim JK Obara CJ Rivollier A: Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J Immunol. 2011;186(1):471-8. 21131425 10.4049/jimmunol.1003003 3402345 F1000 Recommendation
91. Sitati E McCandless EE Klein RS: CD40-CD40 ligand interactions promote trafficking of CD8 + T cells into the brain and protection against West Nile virus encephalitis. J Virol. 2007;81(18):9801-11. 17626103 10.1128/JVI.00941-07 2045405
92. Getts DR Terry RL Getts MT: Ly6c + "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med. 2008;205(10):2319-37. 18779347 10.1084/jem.20080421 2556789 F1000 Recommendation
93. Ben-Nathan D Huitinga I Lustig S: West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol. 1996;141(3-4):459-69. 8645088 10.1007/BF01718310
94. Getts DR Terry RL Getts MT: Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. J Neuroinflammation. 2012;9:246. 23111065 10.1186/1742-2094-9-246 3532418 F1000 Recommendation
95. Lim JK Obara CJ Rivollier A: Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J Immunol. 2011;186(1):471-8. 21131425 10.4049/jimmunol.1003003 3402345
96. Bardina SV Michlmayr D Hoffman KW: Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection. J Immunol. 2015;195(9):4306-18. 26401006 10.4049/jimmunol.1500352 4610864 F1000 Recommendation
97. Rawal A Gavin PJ Sturgis CD: Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis. Diagn Cytopathol. 2006;34(2):127-9. 16511849 10.1002/dc.20410
98. Tyler KL Pape J Goody RJ: CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006;66(3):361-5. 16382032 10.1212/01.wnl.0000195890.70898.1f
99. Wang P Bai F Zenewicz LA: IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One. 2012;7(8):e44153. 22952908 10.1371/journal.pone.0044153 3429482
100. Brien JD Uhrlaub JL Nikolich-Zugich J: West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol. 2008;181(12):8568-75. 19050276 10.4049/jimmunol.181.12.8568 3504655
101. Durrant DM Robinette ML Klein RS: IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J Exp Med. 2013;210(3):503-16. 23460727 10.1084/jem.20121897 3600909 F1000 Recommendation
102. Shrestha B Pinto AK Green S: CD8 + T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons. J Virol. 2012;86(17):8937-48. 22740407 10.1128/JVI.00673-12 3416144 F1000 Recommendation
103. Shrestha B Samuel MA Diamond MS: CD8 + T cells require perforin to clear West Nile virus from infected neurons. J Virol. 2006;80(1):119-29. 16352536 10.1128/JVI.80.1.119-129.2006 1317548
104. Szretter KJ Daniels BP Cho H: 2'- O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog. 2012;8(5):e1002698. 22589727 10.1371/journal.ppat.1002698 3349756
105. Wang Y Lobigs M Lee E: CD8 + T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol. 2003;77(24):13323-34. 14645588 10.1128/JVI.77.24.13323-13334.2003 296062 F1000 Recommendation
106. Lazear HM Pinto AK Ramos HJ: Pattern recognition receptor MDA5 modulates CD8 + T cell-dependent clearance of West Nile virus from the central nervous system. J Virol. 2013;87(21):11401-15. 23966390 10.1128/JVI.01403-13 3807324 F1000 Recommendation
107. Durrant DM Daniels BP Klein RS: IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous system during West Nile Virus encephalitis. J Immunol. 2014;193(8):4095-106. 25200953 10.4049/jimmunol.1401192 4340598 F1000 Recommendation